Novotech presents research into state of biotech industry

Singapore-based Novotech, an Asia-Pacific-focused contract research organization (CRO), has presented research on financial shifts in the biotech industry in 2023.

The company said its work represented a “thorough evaluation of the worldwide financial landscape for biotech clinical trials, offering valuable and actionable insights.”

The research identifies a “convergence of diverse factors, including economic pressures, intense competition, ever-evolving market dynamics, and regulatory changes, is reshaping the industry, impacting both agile biotech startups and well-established pharmaceutical giants alike.”